Berlin, Germany

Ashutosh Banerjee

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Friedrich-Alexander-Universitat Erlangen-Nürnberg. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ashutosh Banerjee: Innovator in Neurotensin Receptor-Related Conditions

Introduction

Ashutosh Banerjee is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of medical science, particularly in the diagnosis, treatment, and prevention of neurotensin receptor-related conditions. His innovative work has the potential to impact the treatment of tumors and hematological malignancies.

Latest Patents

Banerjee holds a patent for a compound described in his invention, which is aimed at addressing neurotensin receptor-related conditions. The patent details a compound of formula (I) that can be utilized in the diagnosis, treatment, or prevention of these conditions. This invention represents a crucial advancement in medical research and therapeutic options.

Career Highlights

Throughout his career, Ashutosh Banerjee has worked with esteemed institutions such as Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Banerjee has collaborated with notable colleagues, including Olaf Prante and Torsten Kuwert. These partnerships have further enriched his research and development efforts in the medical field.

Conclusion

In summary, Ashutosh Banerjee is a dedicated inventor whose work in neurotensin receptor-related conditions showcases his commitment to advancing medical science. His contributions are poised to make a significant impact on the diagnosis and treatment of serious health conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…